Oncology Information System Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report 2026-2030

Oncology information systems encompass a range of software tools designed to support cancer treatment centers, hospitals, and specialty clinics in managing patient data, radiation therapy, chemotherapy regimens, and multidisciplinary care coordination. The market is valued at approximately $3.22 billion in 2025 and is expected to continue expanding through the coming decade, with projections reaching roughly $4.7 billion to $4.8 billion by 2030. Market sizing figures are generated by private research and analytics firms, as no official government statistical agency tracks the total addressable market for this specific product category.

• •Market estimated at $3.22 billion in 2025, with projections varying across research firms from roughly $4.69 billion to $4.80 billion by 2030
• •Products span EHR integration, radiation oncology, medical oncology, and surgical oncology workflow management
• •No government or official statistical agency publishes official market-size figures for this segment

Rising global cancer prevalence is a fundamental driver, with the World Health Organization estimating approximately 20 million new cancer cases annually, increasing demand for digital systems that can manage complex treatment protocols. Government policy and regulatory frameworks, including the 21st Century Cures Act in the United States, have mandated interoperability and information blocking rules that accelerate healthcare IT adoption across oncology settings. Increasing healthcare spending on cancer care, coupled with the shift toward value-based care models, pushes providers to adopt integrated systems that improve efficiency and patient outcomes while reducing administrative overhead.

• •Growing global cancer incidence and aging populations increase demand for digital oncology tools
• •Regulatory mandates such as the 21st Century Cures Act push adoption of interoperable health IT systems
• •Transition to value-based care and precision medicine drives need for integrated, data-rich clinical platforms

The market is typically segmented by product type, including radiation oncology, medical oncology, surgical oncology, and others, with radiation oncology systems holding a significant share due to their complexity and high integration requirements. North America, and particularly the United States, dominates the market, with the U.S. segment alone estimated at approximately $963.88 million in 2025, supported by advanced healthcare infrastructure, favorable reimbursement policies, and high rates of healthcare IT spending. Europe and the Asia-Pacific region represent the next largest markets, with Asia-Pacific expected to grow at the fastest pace as developing nations invest in healthcare modernization.

• •U.S. market alone estimated at approximately $963.88 million in 2025 with a 7.56% CAGR through 2030
• •North America leads globally, followed by Europe and the rapidly expanding Asia-Pacific region
• •Radiation oncology and medical oncology IT segments constitute the largest product categories

What are the recent trends and outlook?

Artificial intelligence and machine learning are increasingly embedded into oncology information systems to assist with treatment planning, clinical decision support, and predictive analytics for patient outcomes. Cloud-based and software-as-a-service deployment models are gaining traction, offering healthcare providers greater scalability, reduced IT infrastructure costs, and improved data accessibility across care sites. The market is expected to remain on a solid growth trajectory through at least 2030, sustained by the convergence of digital health adoption, precision oncology requirements, and continued expansion of cancer care infrastructure in emerging markets.

• •Integration of artificial intelligence for clinical decision support and predictive analytics is accelerating
• •Cloud-based and SaaS deployment models are growing as providers seek scalable and interoperable solutions
• •Market projected to sustain mid-to-high single-digit annual growth through 2030 across all major regions